Summary
This 2021 European Association of Urology guideline document presents a comprehensive update on the clinical management of metastatic urothelial carcinoma, synthesising current evidence on diagnosis, prognosis, and treatment strategies. The guidelines appear to incorporate recent advances in systemic therapy, immunotherapy, and multimodal approaches to treatment selection. As a clinical guideline rather than primary research, it serves to standardise care practices across European urological centres.
UK applicability
These European Association of Urology guidelines are directly applicable to UK urological practice, as the UK participates in evidence harmonisation with European specialist societies. UK practitioners would use these recommendations to inform treatment algorithms and inform patients of standard-of-care options.
Key measures
Treatment protocols, diagnostic criteria, prognostic factors, and therapeutic outcomes in metastatic urothelial carcinoma management
Outcomes reported
The paper reports updated clinical guidelines and recommendations for the diagnosis, staging, and treatment of metastatic urothelial carcinoma based on contemporary evidence review.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.